MedPath

Zoledronic Acid

These highlights do not include all the information needed to use ZOLEDRONIC ACID INJECTION safely and effectively. See full prescribing information for ZOLEDRONIC ACID INJECTION. ZOLEDRONIC ACID injection Initial U.S. Approval: 2001

Approved
Approval ID

16fcf8c9-ef8a-4e93-9ee6-acfadd35a861

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 21, 2023

Manufacturers
FDA

Fresenius Kabi USA, LLC

DUNS: 608775388

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Zoledronic Acid

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63323-966
Application NumberANDA204217
Product Classification
M
Marketing Category
C73584
G
Generic Name
Zoledronic Acid
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 31, 2022
FDA Product Classification

INGREDIENTS (3)

ZOLEDRONIC ACIDActive
Quantity: 5 mg in 100 mL
Code: 6XC1PAD3KF
Classification: ACTIM
SODIUM CITRATEInactive
Code: 1Q73Q2JULR
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Zoledronic Acid - FDA Drug Approval Details